Personalized Nutrition for Cardiometabolic Prevention: Integrating Multi-Omics, Digital Health, Functional Foods, and the Gut Microbiome
Nutrients · 20.11.2026 · 18 (22) · 3874
DOI: 10.3390/nu18223874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 20.11.2026. Verfasst von Muhammad Maaz und 6 weiteren Autor:innen. Die Arbeit nennt 236 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background/Objectives: Tailoring dietary recommendations to an individual’s biological, metabolic, behavioral, and lifestyle factors may be a promising approach for supporting the prevention and management of chronic metabolic disorders.
Methods
This narrative review summarizes the potential significance of personalized nutrition, focusing on digital technologies, functional foods, and the gut microbiota, by reviewing relevant data from PubMed, Scopus, Web of Science, and Google Scholar from 2019 to 2026. The evidence was synthesized narratively to critically evaluate the interactions among these components and their potential translation into clinically relevant cardiometabolic outcomes.
Results
Genetics, epigenetics, metabolic phenotype, gut microbial profile, physical activity, sleep, stress, and other behavioral factors contribute to inter-individual variability in nutritional response. Technologies ranging from mobile health apps to AI and machine learning, wearable devices, continuous glucose monitoring, diet-tracking apps, and tele-nutrition allow real-time monitoring and adjustment of nutrition guidance. Probiotic, prebiotic, synbiotic, dietary fiber, polyphenol, omega-3 fatty acid, and phytosterol interventions could help support metabolic regulation, inflammation control, gut health, and cardiovascular function. Moreover, short-chain fatty acid production, immune regulation, gut–liver–brain signaling, and nutrient metabolism highlight the role of the gut microbiota in contributing to personalized responses.
Conclusions
Emerging evidence suggests potential benefits of personalized nutrition approaches; however, their long-term clinical effectiveness remains insufficiently validated. Moreover, several challenges remain, such as inconsistent validation, heterogeneous study designs, variable evidence regarding functional foods, data privacy concerns, high costs, limited accessibility, digital literacy, and long-term adherence, which hinder clinical translation. Furthermore, the potential attributes of personalized nutrition lie in its coordinated integration; therefore, biological profiling informs targeted dietary interventions and digital monitoring supports continuous evaluation and adaptation.
Förderung
- Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia
Zitieren
APA
Maaz, M., Qureshi, E. Y., Noman, A. M., Khalid, M. U., Weiskirchen, R., Elkatry, H. O., & Sultan, M. T. (2026). Personalized Nutrition for Cardiometabolic Prevention: Integrating Multi-Omics, Digital Health, Functional Foods, and the Gut Microbiome. Nutrients, 18(22), 3874. https://doi.org/10.3390/nu18223874
Vancouver
Maaz M, Qureshi EY, Noman AM, Khalid MU, Weiskirchen R, Elkatry HO, et al. Personalized Nutrition for Cardiometabolic Prevention: Integrating Multi-Omics, Digital Health, Functional Foods, and the Gut Microbiome. Nutrients. 2026;18(22):3874. doi:10.3390/nu18223874
BibTeX
@article{Maaz2026,
author = {Maaz, Muhammad and Qureshi, Eisha Yaqoob and Noman, Ahmad Mujtaba and Khalid, Muhammad Usman and Weiskirchen, Ralf and Elkatry, Haiam O. and Sultan, Muhammad Tauseef},
title = {Personalized Nutrition for Cardiometabolic Prevention: Integrating Multi-Omics, Digital Health, Functional Foods, and the Gut Microbiome},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {22},
pages = {3874},
doi = {10.3390/nu18223874}
}
EUVIMED